vs
BALCHEM CORP（BCPC）与LifeStance Health Group, Inc.（LFST）财务数据对比。点击上方公司名可切换其他公司
LifeStance Health Group, Inc.的季度营收约是BALCHEM CORP的1.4倍（$382.2M vs $270.7M），BALCHEM CORP净利率更高（14.9% vs 3.1%，领先11.8%），LifeStance Health Group, Inc.同比增速更快（17.4% vs 8.1%），LifeStance Health Group, Inc.自由现金流更多（$46.6M vs $33.8M），过去两年LifeStance Health Group, Inc.的营收复合增速更高（12.8% vs 7.5%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
LifeStance Health Group是美国的门诊行为健康服务提供商，支持线下面诊与远程诊疗两种服务模式，业务涵盖心理咨询、精神科诊疗、经颅磁刺激（TMS）以及氯胺酮治疗等。该公司曾多次因劳动违规、客户信息泄露及误导投资者相关问题遭遇诉讼。
BCPC vs LFST — 直观对比
营收规模更大
LFST
是对方的1.4倍
$270.7M
营收增速更快
LFST
高出9.4%
8.1%
净利率更高
BCPC
高出11.8%
3.1%
自由现金流更多
LFST
多$12.8M
$33.8M
两年增速更快
LFST
近两年复合增速
7.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.7M | $382.2M |
| 净利润 | $40.3M | $11.7M |
| 毛利率 | — | — |
| 营业利润率 | 20.5% | 4.7% |
| 净利率 | 14.9% | 3.1% |
| 营收同比 | 8.1% | 17.4% |
| 净利润同比 | 8.7% | 264.1% |
| 每股收益（稀释后） | $1.25 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCLFST
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $382.2M | ||
| Q3 25 | $267.6M | $363.8M | ||
| Q2 25 | $255.5M | $345.3M | ||
| Q1 25 | $250.5M | $333.0M | ||
| Q4 24 | $240.0M | $325.5M | ||
| Q3 24 | $239.9M | $312.7M | ||
| Q2 24 | $234.1M | $312.3M |
净利润BCPCLFST
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $11.7M | ||
| Q3 25 | $40.3M | $1.1M | ||
| Q2 25 | $38.3M | $-3.8M | ||
| Q1 25 | $37.1M | $709.0K | ||
| Q4 24 | $33.6M | $-7.1M | ||
| Q3 24 | $33.8M | $-6.0M | ||
| Q2 24 | $32.1M | $-23.3M |
毛利率BCPCLFST
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
营业利润率BCPCLFST
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | 4.7% | ||
| Q3 25 | 20.4% | 2.0% | ||
| Q2 25 | 20.1% | -0.9% | ||
| Q1 25 | 20.4% | 0.5% | ||
| Q4 24 | 19.8% | 0.3% | ||
| Q3 24 | 20.0% | 0.0% | ||
| Q2 24 | 19.6% | -5.1% |
净利率BCPCLFST
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 3.1% | ||
| Q3 25 | 15.1% | 0.3% | ||
| Q2 25 | 15.0% | -1.1% | ||
| Q1 25 | 14.8% | 0.2% | ||
| Q4 24 | 14.0% | -2.2% | ||
| Q3 24 | 14.1% | -1.9% | ||
| Q2 24 | 13.7% | -7.5% |
每股收益（稀释后）BCPCLFST
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | — | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.13 | — | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $248.6M |
| 总债务越低越好 | — | $282.8M |
| 股东权益账面价值 | $1.3B | $1.5B |
| 总资产 | $1.7B | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资BCPCLFST
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $248.6M | ||
| Q3 25 | $65.1M | $203.9M | ||
| Q2 25 | $65.4M | $188.9M | ||
| Q1 25 | $49.9M | $134.3M | ||
| Q4 24 | $49.5M | $154.6M | ||
| Q3 24 | $73.7M | $102.6M | ||
| Q2 24 | $63.7M | $87.0M |
总债务BCPCLFST
| Q1 26 | — | — | ||
| Q4 25 | — | $282.8M | ||
| Q3 25 | — | $284.6M | ||
| Q2 25 | — | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | — | $290.0M | ||
| Q3 24 | — | $287.3M | ||
| Q2 24 | — | $288.0M |
股东权益BCPCLFST
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.3B | $1.5B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $1.2B | $1.4B | ||
| Q2 24 | $1.1B | $1.4B |
总资产BCPCLFST
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.1B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.6B | $2.1B | ||
| Q4 24 | $1.6B | $2.1B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.6B | $2.1B |
负债/权益比BCPCLFST
| Q1 26 | — | — | ||
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.19× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $40.1M | $57.6M |
| 自由现金流经营现金流 - 资本支出 | $33.8M | $46.6M |
| 自由现金流率自由现金流/营收 | 12.5% | 12.2% |
| 资本支出强度资本支出/营收 | 2.3% | 2.9% |
| 现金转化率经营现金流/净利润 | 0.99× | 4.93× |
| 过去12个月自由现金流最近4个季度 | — | $110.0M |
8季度趋势，按日历期对齐
经营现金流BCPCLFST
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $57.6M | ||
| Q3 25 | $65.6M | $27.3M | ||
| Q2 25 | $47.3M | $64.4M | ||
| Q1 25 | $36.5M | $-3.1M | ||
| Q4 24 | $52.3M | $62.3M | ||
| Q3 24 | $51.3M | $22.7M | ||
| Q2 24 | $45.0M | $44.1M |
自由现金流BCPCLFST
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $46.6M | ||
| Q3 25 | — | $17.0M | ||
| Q2 25 | — | $56.6M | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | — | $56.0M | ||
| Q3 24 | — | $17.7M | ||
| Q2 24 | — | $39.0M |
自由现金流率BCPCLFST
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | 12.2% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | -3.1% | ||
| Q4 24 | — | 17.2% | ||
| Q3 24 | — | 5.7% | ||
| Q2 24 | — | 12.5% |
资本支出强度BCPCLFST
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 1.6% |
现金转化率BCPCLFST
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 4.93× | ||
| Q3 25 | 1.63× | 25.34× | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | -4.36× | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
